Literature DB >> 29649782

Balloon pulmonary angioplasty in a patient with prostate cancer and chronic thromboembolic pulmonary hypertension.

Yolanda Bryce1, Ernesto Santos2.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension characterized by a mean pulmonary artery pressure ≥25 mm Hg due to obstructive fibrotic thromboembolic material in the pulmonary arteries. Malignancy is a significant risk for developing CTEPH. The option for inoperable CTEPH is largely medical with variable outcomes. Balloon pulmonary angioplasty (BPA) is a promising option for inoperable patients given distal-type CTEPH, co-morbidities, or residual pulmonary hypertension after surgery. We present a case of a patient with prostate cancer and CTEPH successfully treated with balloon pulmonary angioplasty.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Balloon pulmonary angioplasty; Chronic thromboembolic pulmonary hypertension

Mesh：

Year:  2018        PMID： 29649782      PMCID： PMC8985418          DOI： 10.1016/j.clinimag.2018.04.004

Source DB:  PubMed          Journal:  Clin Imaging        ISSN： 0899-7071            Impact factor:   1.605


  17 in total

Review 1.  Chronic thromboembolic pulmonary hypertension.

Authors:  P F Fedullo; W R Auger; K M Kerr; L J Rubin
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Ramona L Doyle; Douglas McCrory; Richard N Channick; Gerald Simonneau; John Conte
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 3.  Chronic thromboembolic pulmonary hypertension: a distinct disease entity.

Authors:  Irene Lang
Journal:  Eur Respir Rev       Date:  2015-06

4.  Prognostic factors in medically treated patients with chronic pulmonary embolism.

Authors:  J Lewczuk; P Piszko; J Jagas; A Porada; S Wójciak; B Sobkowicz; K Wrabec
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

5.  Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience.

Authors:  Marcin Kurzyna; Szymon Darocha; Radosław Pietura; Arkadiusz Pietrasik; Justyna Norwa; Rafał Mańczak; Maria Wieteska; Andrzej Biederman; Hiromi Matsubara; Adam Torbicki
Journal:  Kardiol Pol       Date:  2017-05-29       Impact factor: 3.108

6.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Raffaele Pesavento; Mauro Silingardi; Renzo Poggio; Maria Rita Taliani; Walter Ageno
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

7.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Authors:  M Riedel; V Stanek; J Widimsky; I Prerovsky
Journal:  Chest       Date:  1982-02       Impact factor: 9.410

8.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

9.  Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hiroki Mizoguchi; Aiko Ogawa; Mitsuru Munemasa; Hiroshi Mikouchi; Hiroshi Ito; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2012-11-27       Impact factor: 6.546

10.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.